Inmolecule Nanotech, S.A.
MLINA | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- ES0105908000
- LEI:
- 959800F0D3TQYVTXW034
- Country:
- Spain
- Address:
- N/A
- Website:
- https://www.inmolecule.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Inmolecule Nanotech, S.A. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Inmolecule Nanotech, S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inmolecule Nanotech, S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Advancing therapeutics for metabolic, dermatologic, and inflammatory diseases.
United States of America
HOTH
United States of America
HOTH
A biotech investor developing gene therapy, regenerative medicine, and genetic services.
Russian Federation
ISKJ
Russian Federation
ISKJ
A CRO running human challenge trials to test infectious disease vaccines for pharma/biotech clients.
United Kingdom
HVO
United Kingdom
HVO
R&D provider of molecular interaction analysis to accelerate drug discovery for life science sectors.
France
ALHYG
France
ALHYG
South Korea
187660
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea
048410
South Korea
048410
Global CRO providing outsourced development & commercialization for pharma, biotech & device firms.
United States of America
ICLR
United States of America
ICLR
Clinical-stage pharma creating Alzheimer's therapies & AI-powered diagnostics.
United States of America
IGC
United States of America
IGC
Personal biobank preserving umbilical cord stem cells for families' future therapeutic use.
Russian Federation
GEMA
Russian Federation
GEMA
Clinical-stage oncology firm using bioinformatics to develop oral MEK inhibitors for solid tumors.
United States of America
IMRX
United States of America
IMRX